Market Research Logo

Shionogi & Co Ltd - Product Pipeline Review - 2016

Shionogi & Co Ltd - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Shionogi & Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Shionogi & Co Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Shionogi & Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Shionogi & Co Ltd
  • The report provides overview of Shionogi & Co Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Shionogi & Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Shionogi & Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Shionogi & Co Ltd’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Shionogi & Co Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Shionogi & Co Ltd’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Introduction
Global Markets Direct Report Coverage
Shionogi & Co Ltd Snapshot
Shionogi & Co Ltd Overview
Key Facts
Shionogi & Co Ltd - Research and Development Overview
Key Therapeutic Areas
Shionogi & Co Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Shionogi & Co Ltd - Pipeline Products Glance
Shionogi & Co Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Shionogi & Co Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Shionogi & Co Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Shionogi & Co Ltd - Drug Profiles
A-2NTX - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AMG-0101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
asapiprant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cefiderocol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
doripenem - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lusutrombopag - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody to Inhibit PcrV for Resistant Pseudomonas aeruginosa Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naldemedine tosylate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ospemifene - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
oxycodone hydrochloride ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide to Agonize NPR1 and NPR2 for Non-Small Cell Lung Cancer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rovatirelin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-010887 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-033188 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-117957 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-120083 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-222611 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-237648 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-488210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-588410 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-600918 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
S-707106 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize P2X3 Receptor for Neuropathic Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Block TRPV4 for Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Tuberculosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Agonize CB2 for Pruritus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize NPY5R for Obesity - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Penicillin Binding Protein for Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SR-0379 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
STAGR-120 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
standardized mite (Dermatophagoides farinae + Dermatophagoides pteronyssinus) allergen extract - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Shionogi & Co Ltd - Pipeline Analysis
Shionogi & Co Ltd - Pipeline Products by Target
Shionogi & Co Ltd - Pipeline Products by Route of Administration
Shionogi & Co Ltd - Pipeline Products by Molecule Type
Shionogi & Co Ltd - Pipeline Products by Mechanism of Action
Shionogi & Co Ltd - Dormant Projects
Shionogi & Co Ltd - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ADX-415
capravirine
doripenem
GSK-364735
GW-810781
lisdexamfetamine dimesylate
lusutrombopag
S-234462
S-288310
S-444823
S-488410
S-5751
S-646240
S-777469
S-8510
teceleukin
varespladib sodium
velneperit
Shionogi & Co Ltd - Company Statement
Shionogi & Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Shionogi & Co Ltd, Key Facts
Shionogi & Co Ltd - Pipeline by Indication, 2016
Shionogi & Co Ltd - Pipeline by Stage of Development, 2016
Shionogi & Co Ltd - Monotherapy Products in Pipeline, 2016
Shionogi & Co Ltd - Combination Treatment Modalities in Pipeline, 2016
Shionogi & Co Ltd - Partnered Products in Pipeline, 2016
Shionogi & Co Ltd - Partnered Products/ Combination Treatment Modalities, 2016
Shionogi & Co Ltd - Out-Licensed Products in Pipeline, 2016
Shionogi & Co Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2016
Shionogi & Co Ltd - Pre-Registration, 2016
Shionogi & Co Ltd - Phase III, 2016
Shionogi & Co Ltd - Phase II, 2016
Shionogi & Co Ltd - Phase I, 2016
Shionogi & Co Ltd - Preclinical, 2016
Shionogi & Co Ltd - Discovery, 2016
Shionogi & Co Ltd - Pipeline by Target, 2016
Shionogi & Co Ltd - Pipeline by Route of Administration, 2016
Shionogi & Co Ltd - Pipeline by Molecule Type, 2016
Shionogi & Co Ltd - Pipeline Products by Mechanism of Action, 2016
Shionogi & Co Ltd - Dormant Developmental Projects,2016
Shionogi & Co Ltd - Discontinued Pipeline Products, 2016
Shionogi & Co Ltd, Other Locations
Shionogi & Co Ltd, Subsidiaries
List of Figures
Shionogi & Co Ltd - Pipeline by Top 10 Indication, 2016
Shionogi & Co Ltd - Pipeline by Stage of Development, 2016
Shionogi & Co Ltd - Monotherapy Products in Pipeline, 2016
Shionogi & Co Ltd - Partnered Products in Pipeline, 2016
Shionogi & Co Ltd - Out-Licensed Products in Pipeline, 2016
Shionogi & Co Ltd - Pipeline by Top 10 Target, 2016
Shionogi & Co Ltd - Pipeline by Route of Administration, 2016
Shionogi & Co Ltd - Pipeline by Molecule Type, 2016
Shionogi & Co Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report